Rejuvenating a cell, or the biological breakthrough of the century
While we talk about artificial intelligence, a quieter revolution is redefining what ageing actually is.
Delaying Alzheimer's by three years would have the same effect as curing all cancers today.
Altos Labs and Life Biosciences are revolutionising longevity science, building on the work of Shinya Yamanaka, Juan Carlos Izpisua Belmonte and David A. Sinclair.
Between 2006 and 2026, we have moved from a laboratory curiosity to a regulated clinical reality. Ageing has changed status: from a 'biological destiny', it has become a repairable mechanism.
The challenge of the next five years will be equitable access to these therapies and fine mastery of dosage, to turn reactive medicine into a systemic restoration medicine.